Delivering the Stem Cell Goods: California's Targets for the Next Five Years
Manufacturing Partnerships, a Roadmap to Affordability, 'Knowledge Networks'and More
California’s $12 billion stem cell agency is looking to dive ever deeper into late-stage research, optimizing its financing for clinical trials and working to “overcome manufacturing hurdles” that are delaying the delivery of therapies.
It is all part of the agency’s proposed strategic plan for the next five years, which is aimed at making good on the 2…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.